NHS Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)

Concepts

• runcorn
• pharmaceutical products
• nhs framework
• insulin aspart biosimilar
• branded medicines -tranche b
• annual tranche products
• annual tranche
• england
• cm/phr/20/5600/03- nhs framework
• branded medicines - tranche b

Location

Geochart for 1 buyers and 0 suppliers

NHS England

+−

Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 01 - Invitation to offer covering letter (A2486901)#3 Document No. 01 - Invitation to offer covering letter (A2486901)#3.doc Document No. 02 - Terms of offer Document No. 02 - Terms of offer.doc Document No. 04 - Contract technical specification (A2383497) Document No. 04 - Contract technical specification (A2383497).doc Document No. 07a - Quality control technical sheet (A2383499) Document No. 07a - Quality control technical sheet (A2383499).doc Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.docx Document No. 05 - Selectt offer schedule instructions (A2383501) Document No. 05 - Selectt offer schedule instructions (A2383501).doc Document No. 05b(ii) - Tender Product Listing and Usage - CM_PHR_20_5600_02 Document No. 05b(ii) - Tender Product Listing and Usage - CM_PHR_20_5600_02.xlsx Document No. 05c - Volume discounts or Additional Products Offer Schedule Document No. 05c - Volume discounts or Additional Products Offer Schedule.xls Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS (A2383503) Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS (A2383503).doc Document No. 05b(v) - Tender Product Listing and Usage - CM_PHR_20_5600_05 Document No. 05b(v) - Tender Product Listing and Usage - CM_PHR_20_5600_05.xlsx Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_20_5600_01 Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_20_5600_01.xlsx Document No. 06 - Form of offer (A2383498) Document No. 06 - Form of offer (A2383498).doc Document No. 05b(iii) - Tender Product Listing and Usage - CM_PHR_20_5600_03 Document No. 05b(iii) - Tender Product Listing and Usage - CM_PHR_20_5600_03.xlsx Document No. 05b(iv) - Tender Product Listing and Usage - CM_PHR_20_5600_04 Document No. 05b(iv) - Tender Product Listing and Usage - CM_PHR_20_5600_04.xlsx Document No.10 - Participating Authorities Document No.10 - Participating Authorities.xlsx Document No. 08 - Confidential information schedule (A2383500) Document No. 08 - Confidential information schedule (A2383500).xls Document No. 09 - Tender Design and Guidance on completing the ITO Document No. 09 - Tender Design and Guidance on completing the ITO.doc Document No. 05a( i, ii, iii,iv,v ) CM_PHR_20_5600_00 SELECTT Application Document No. 05a( i, ii, iii,iv,v ) CM_PHR_20_5600_00 SELECTT Application.docx